TREATMENT BURDEN AND PATIENT PREFERENCE IN PATIENTS WITH HEMOPHILIA A OR B WITH INHIBITORS ON CONCIZUMAB PROPHYLAXIS: RESULTS FROM THE PHASE 3 EXPLORER7 STUDY K Hampton; P Knoebl; J Odgaard-Jensen; O Stasyshyn; JJT Zaw; JS Neergaard; B Zulfikar; GG Fabbron;

A USABILITY STUDY ASSESSING HANDLING AND PREFERENCE OF THE CONCIZUMAB PEN-INJECTOR IN PATIENTS WITH HAEMOPHILIA AND CAREGIVERS NK Rasmussen; B Berg; JS Neergaard; S Shah; G Ter-Borch; T Sparre; GG Fabbron;

ASSOCIATION OF ANTITHROMBIN LEVELS WITH EFFICACY OF FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A OR B, WITH AND WITHOUT INHIBITORS: A PREDICTIVE MODELING APPROACH G Young; K Kavakli; M Shen; A Srivastava; J Sun; H Tran; J Chi; A Youn; M Puurunen; SW Pipe;